Publication:
Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children

dc.contributor.authorWiparat Manuyakornen_US
dc.contributor.authorPlernpit Likkasittipanen_US
dc.contributor.authorSukanya Wattanapokayakiten_US
dc.contributor.authorSupharat Suvichapanichen_US
dc.contributor.authorWimala Inunchoten_US
dc.contributor.authorNuanjun Wichukchindaen_US
dc.contributor.authorChaiyos Khongkhatithumlen_US
dc.contributor.authorLunliya Thampratankulen_US
dc.contributor.authorWasu Kamchaisatianen_US
dc.contributor.authorSuwat Benjaponpitaken_US
dc.contributor.authorSurakameth Mahasirimongkolen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherThailand Ministry of Public Healthen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2020-05-05T05:34:17Z
dc.date.available2020-05-05T05:34:17Z
dc.date.issued2020-05-01en_US
dc.description.abstract© 2020 Elsevier B.V. Purpose: Phenytoin (PHT) is a common causative drug for severe cutaneous adverse drug reactions (SCARs) in children. SCARs, including drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), are associated with a variation in HLA genotypes. Blood screening for specific HLA allele before PHT prescription would help in the reduction of the incidence of PHT induced SCARs. This study was to investigate the association between variations of HLA genotypes and PHT induced SCARs in Thai children. Methods: Cases were Thai children aged between 0–18 years diagnosed with SCARs from PHT. Control groups were Thai children of corresponding age who had taken PHT for a least 12 weeks without any hypersensitivity reaction and healthy population controls. Blood samples from both groups were collected for HLA genotyping using a reverse-sequence specific oligonucleotide (SSO) probes method. Carrier rates of HLA alleles were compared between 22 cases (17 DRESS and 5 SJS-TEN), 60 tolerant controls and 649 population controls. Results: Two HLA alleles includingHLA-B*51:01 and HLA-C*14:02 were significantly associated with PHT induced DRESS (OR 5.83; 95 % CI 1.36–25.00, p = 0.022 and OR 5.85; 95 % CI 1.16–29.35, p = 0.039). HLA-B*38:02 was significantly associated with PHT induced SJS-TEN (OR12.67; 95 % CI 1.50–106.89, p = 0.044). Haplotype analysis demonstrated the association of HLA haplotype A*11:01-B*51:01-C*14:02 and PHT induced DRESS compared to tolerant controls and the healthy population control group (OR 8.92; 95 % CI 1.47–54.02, p = 0.019, and OR 10.2; 95 % CI 3.04–34.21, p = 0.002). HLA haplotype B*38:02-C*07:01 in PHT induced SJS-TEN was significantly higher than those in tolerant controls and the healthy population control group (40 % vs 3.3 % vs 0.3 %; OR 19.33; 95 % CI 1.98–188.59, p = 0.027 and OR 215.67; 95 % CI 22.40–2076.04, p = 0.0003. HLA-B*15:02 was not associated with PHT induced SCARs. Significance: An association betweenHLA-B*51:01 and HLA-C*14:02 and PHT induced DRESS and HLA-B*38:02 and PHT induced SJS-TEN has been demonstrated in Thai children.en_US
dc.identifier.citationEpilepsy Research. Vol.162, (2020)en_US
dc.identifier.doi10.1016/j.eplepsyres.2020.106321en_US
dc.identifier.issn18726844en_US
dc.identifier.issn09201211en_US
dc.identifier.other2-s2.0-85082837050en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/54595
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85082837050&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectNeuroscienceen_US
dc.titleAssociation of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai childrenen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85082837050&origin=inwarden_US

Files

Collections